Incidence and Factor Associated with Dengue Shock Syndrome and Clinical Outcomes of Dengue Hemorrhagic Fever in Pediatric Patients at Chaoprayayommarat Hospital.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210805002

Enrollment

236

Registered

2021-08-05

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

no problems clinical outcome, dengue hemorrhagic fever, dengue shock syndrome, risk factors

Interventions

dengue hemorrhagic fever according to WHO criteria classified as Grade I was defined as fever and hemorrhagic manifestation (positive tourniquet test), Grade II as in Grade I plus spontaneous bleedin

Treatment,Treatment

Dengue hemorrhagic fever -non shock group(GradeI&amp

GradeII),Dengue shock syndrome (DSS)-shock group(GradeIII&amp

GradeIV)

Eligibility

Sex/Gender

All

Age

1 Days to 15 Years

Inclusion criteria

Inclusion criteria: the children below 15 of age and diagnosed with DHF/DSS according to WHO criteria(2011).

Exclusion criteria

Exclusion criteria: the children who have entered the recovery phase on admission.

Design outcomes

Primary

Measure	Time frame
Incidences of dengue shock syndrome in pediatric patients 1 year A retrospective cohorts study	—

Secondary

Measure	Time frame
Identification of risk factors associated with dengue shock syndrome and treatment outcomes of dengue hemorrhagic fever in pediatric patients 1 year A retrospective cohorts study	—

Countries

Thailand

Contacts

Public ContactThunyakorn Nuntiyagul

Chaoprayayommarat Hospital

thunyakorn.n2515@gmail.com0819257444

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026